glp-1/gip/glucagon triple agonist name GLP-1 / GIP / Glucagon Receptor (CAS 2381089-83-2) Targeting GLP-1, GIP & GCG
Description
IP ), sCT + liraglutide or vehicle (Fig
doi: 10.1016/j.tibs.2009.02.004
Ozempics Focus on GLP-1: Ozempic, on the other hand, works specifically as a GLP-1 receptor agonist
While the study was observational (meaning that causality cant be confirmed), it does add to the growing body of evidence suggesting that its worth investigating these weight-loss drugs as potential cancer prevention tools, says lead author, Professor Elizabeth McDonald
Therapeutic strategies for neurodegenerative disorders have commonly targeted individual pathological processes
doi: 10.1016/j.ajem.2024.01.010
